Protection of Mice from Wild-type Sendai Virus Infection by a Trypsin-resistant Mutant, TR-2
Overview
Affiliations
A trypsin-resistant mutant of Sendai virus, TR-2, which could be activated by chymotrypsin but not by trypsin or the protease present in mouse lung, was inoculated intranasally into mice after being activated in vitro. TR-2 hardly brought about clinical illness or lung lesions in mice; the protease present in the lung could not activate the progeny virus, and the infection terminated after one-step replication. Nevertheless, the immunoglobulin A antibody against wild-type Sendai virus was produced in the respiratory tracts as well as the serum immunoglobulin G antibody, and the mice were protected from the challenge of the wild-type Sendai virus. On the basis of these results, TR-2 may provide a new model of live vaccine for paramyxoviruses; its availability as a live vaccine is also discussed.
First Isolation and Characteristics of Bovine Parainfluenza Virus Type 3 from Yaks.
Ren Y, Chen X, Tang C, Yue H Pathogens. 2022; 11(9).
PMID: 36145395 PMC: 9503188. DOI: 10.3390/pathogens11090962.
Matsunaga S, Kawakami S, Matsuo I, Okayama A, Tsukagoshi H, Kudoh A Front Microbiol. 2014; 5:208.
PMID: 24860558 PMC: 4026691. DOI: 10.3389/fmicb.2014.00208.
Henrickson K Clin Microbiol Rev. 2003; 16(2):242-64.
PMID: 12692097 PMC: 153148. DOI: 10.1128/CMR.16.2.242-264.2003.
Protection of mice from respiratory Sendai virus infections by recombinant vaccinia viruses.
Takao S, Kiyotani K, Sakaguchi T, Fujii Y, Seno M, Yoshida T J Virol. 1997; 71(1):832-8.
PMID: 8985426 PMC: 191127. DOI: 10.1128/JVI.71.1.832-838.1997.
Wang X, Itoh M, Hotta H, Homma M J Virol. 1994; 68(5):3369-73.
PMID: 8151795 PMC: 236828. DOI: 10.1128/JVI.68.5.3369-3373.1994.